昭栄薬品株式会社
Ranked #2,249 among listed Japanese companies by corporate taxes paid · effective tax rate 23.2%.
Share price at fiscal year-end: ¥1,564 · market capitalization ¥5.6B · P/E 9.6 · P/B 0.59
US dollar amounts use ¥157.8 per dollar.
| Fiscal year | Revenue | Net income | Tax expense | Taxes paid | Total assets | Net assets | Equity ratio | Source |
|---|---|---|---|---|---|---|---|---|
| Mar 2026 | ¥26.9B | ¥557M | ¥168M | ¥222M | ¥17.8B | ¥9.4B | 52.9% | EDINET (consol.) |
| Mar 2025 | ¥25.0B | ¥527M | ¥230M | ¥187M | ¥17.1B | ¥8.9B | 52.3% | EDINET (consol.) |
| Mar 2024 | ¥22.6B | ¥492M | — | — | ¥16.8B | ¥8.1B | 48.4% | EDINET (consol.) |
| Mar 2023 | ¥24.5B | ¥485M | — | — | ¥14.8B | ¥7.4B | 49.8% | EDINET (consol.) |
| Mar 2022 | ¥21.1B | ¥579M | — | — | ¥14.5B | ¥7.0B | 48.0% | EDINET (consol.) |
From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)
See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.